Search for: "Bristol Myers Squibb Manufacturing Company"
Results 81 - 100
of 161
Sort by Relevance
|
Sort by Date
16 Apr 2014, 12:18 pm
See Bristol-Myers Squibb Co. v. [read post]
16 Apr 2014, 12:18 pm
See Bristol-Myers Squibb Co. v. [read post]
13 Apr 2014, 8:59 am
Bristol-Myers Squibb Co. v. [read post]
3 Apr 2014, 9:55 pm
Bristol-Myers Squibb Company v. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
19 Feb 2014, 6:57 am
• Bristol-Myers Squibb Company • Celgene Corporation • GE Healthcare Inc. [read post]
30 Dec 2013, 5:25 am
Bristol-Myers Squibb Co., 916 F. [read post]
11 Dec 2013, 4:30 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
29 Jul 2013, 2:24 am
Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]
28 Jul 2013, 9:29 am
Januvia and Janumet (Manufactured by Merck) Bydureon (Made by Bristol-Myers Squibb) Onglyza (Made by AstraZeneca) Victoza (Manufactured by Novo Nordisk) Tradjenta (Manufactured by both Eli Lilly and Boehringer Ingelheim; Actos (Manufactured from Takeda) Click here to view the embedded video. . . . [read post]
14 Jun 2013, 6:23 pm
The Food and Drug Administration said it is considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co. [read post]
12 Jun 2013, 12:50 pm
The concerns relate to a number of widely prescribed GLP-1–based therapies, the 2 injectable GLP-1 agonists, exenatide (Byetta, Amylin/Lilly) and liraglutide (Victoza, Novo Nordisk), and the oral DPP-4 inhibitors sitagliptin, saxagliptin (Ongylza, AstraZeneca/Bristol-Myers Squibb), and linagliptin (Tradjenta, Boehringer Ingelheim/Lilly). [read post]
10 Jun 2013, 11:23 am
Thakur began his work at Ranbaxy in early 2004 after he was recruited from the brand-name pharmaceutical company Bristol-Myers Squibb (BMY) based out of New Jersey. [read post]
6 Jun 2013, 5:00 am
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
5 Jun 2013, 5:29 am
Bristol-Myers Squibb, 97 F. [read post]
30 Apr 2013, 12:14 pm
Bristol-Myers Squibb Company, 2013 U.S. [read post]
13 Feb 2013, 11:49 pm
For those interested, the Indian patent number is 213457 and the case details are: Bristol-Myers Squibb Company v. [read post]
31 Jan 2013, 2:39 pm
Earlier in February, 2006 Emcure entered into a similar deal with Bristol Myers Squibbs (BMS) for the manufacture of atanzanavir. [read post]
24 Jan 2013, 11:49 am
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
